title: Basilar-type migraine patients responsive to lamotrigine: a 5-year follow-up.
abstract: Five years ago we reported the case of three patients affected by basilar-type migraine (BM) responsive to lamotrigine. At that time, proven treatment options for BM are rather limited and lamotrigine has been tested in BM patients because it was a widely tested treatment for migraine with aura. That positive 1-year experience leaded us to suggest that lamotrigine could be a preventive therapeutic option for BM patients, with and without menstruation association. We now report the five-year follow-up of the same patients to confirm and underlie the possible role of lamotrigine to induce BM attacks remission.
authors.affiliation: Department of Neuroscience, Institute of Clinical Neurophysiology, Azienda Ospedaliero-Universitaria, Ospedali Riuniti, Foggia, Italy. danielacologno@virgilio.it
authors.forename: D
authors.initials: D
authors.lastname: Cologno
authors.forename: F
authors.initials: F
authors.lastname: d'Onofrio
authors.forename: O
authors.initials: O
authors.lastname: Castriota
authors.forename: V
authors.initials: V
authors.lastname: Petretta
authors.forename: G
authors.initials: G
authors.lastname: Casucci
authors.forename: A
authors.initials: A
authors.lastname: Russo
authors.forename: G
authors.initials: G
authors.lastname: Bussone
mesh_terms: D000328:Adult; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000077213:Lamotrigine; D020325:Migraine with Aura / Q000188:drug therapy*; D014227:Triazines / Q000627:therapeutic use*
chemical_list: D018691:Excitatory Amino Acid Antagonists; D014227:Triazines; D000077213:Lamotrigine